Safety and efficacy of anti-CD20 immunotoxin MT-3724 in relapsed/refractory (R/R) B-cell non-Hodgkin lymphoma (NHL) in a phase I study Meeting Abstract

  

Authors:	Fanale, M. A.; Hamlin, P. A.; Park, S. I.; Persky, D. O.; Higgins, J. P.; Burnett, C.; Dabovic, K.; Poma, E.; Sarapa, N.; Younes, A.
Abstract Title:	Safety and efficacy of anti-CD20 immunotoxin MT-3724 in relapsed/refractory (R/R) B-cell non-Hodgkin lymphoma (NHL) in a phase I study
Meeting Title:	54th Annual Meeting of the American Society of Clinical Oncology (ASCO)
Journal Title:	Journal of Clinical Oncology
Volume:	36
Issue:	15 Suppl.
Meeting Dates:	2018 Jun 1-5
Meeting Location:	Chicago, IL
ISSN:	0732-183X
Publisher:	American Society of Clinical Oncology
Date Published:	2018-05-20
Start Page:	419s
Language:	English
ACCESSION:	WOS:000442916003046
DOI:	10.1200/JCO.2018.36.15_suppl.7580
PROVIDER:	wos
Notes:	Meeting Abstract: 7580 -- Source: Wos

https://synapse.mskcc.org/synapse/works/has_related_data_chk/169457